Clinical Trial Update: Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

This update presents the clinical results of the experimental drug Odyliresin for symptomatic benign prostatic hyperplasia from a completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Benign Prostatic Hyperplasia with Bladder Outlet Obstruction

Drugs mentioned

• Odyliresin (Iresine celosia)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Benign Prostatic Hypertrophy With Outflow Obstruction, Benign Prostatic Hyperplasia | NA | Status: COMPLETED